Works matching Melphalan
Results: 3035
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2233, doi. 10.1007/s00277-023-05308-0
- By:
- Publication type:
- Article
Hybrid Molecules of Benzylguanidine and the Alkylating Group of Melphalan: Synthesis and Effects on Neuroblastoma Cells.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4469, doi. 10.3390/jcm12134469
- By:
- Publication type:
- Article
Stability of Captisol-enabled versus propylene glycol–based melphalan at room temperature and after refrigeration.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 12, p. 1011, doi. 10.1093/ajhp/zxac055
- By:
- Publication type:
- Article
Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection.
- Published in:
- Pharmaceutical Development & Technology, 2018, v. 23, n. 10, p. 1024, doi. 10.1080/10837450.2016.1265557
- By:
- Publication type:
- Article
Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 14, p. 3484, doi. 10.1080/10428194.2020.1811275
- By:
- Publication type:
- Article
High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 1, p. 149, doi. 10.1111/bcp.12906
- By:
- Publication type:
- Article
Long-term outcomes of busulfan plus melphalan-based versus melphalan 200 mg/m<sup>2</sup> conditioning regimens for autologous hematopoietic stem cell transplantation in patients with multiple myeloma: a systematic review and meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- Literature Review
Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 579, doi. 10.1177/1078155220927436
- By:
- Publication type:
- Article
Evaluating the adverse effects of melphalan formulations.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1631, doi. 10.1177/1078155218804042
- By:
- Publication type:
- Article
Cyclical 10‐day dosing of melphalan for canine multiple myeloma.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 3, p. 533, doi. 10.1111/vco.12916
- By:
- Publication type:
- Article
Oral melphalan for the treatment of relapsed canine lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E123, doi. 10.1111/vco.12356
- By:
- Publication type:
- Article
Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00404-1
- By:
- Publication type:
- Article
Evaluation of gastrointestinal complications in Egyptian patients after autologous stem cell transplantation using melphalan-based regimens.
- Published in:
- Egyptian Journal of Internal Medicine, 2023, v. 35, n. 1, p. 1, doi. 10.1186/s43162-023-00213-4
- By:
- Publication type:
- Article
Efficacy and Safety of Melphalan, Cyclophosphamide and Dexamethasone (MCD) as a Salvage Treatment for Patients with Relapsed/Refractory Multiple Myeloma.
- Published in:
- Chonnam Medical Journal, 2019, v. 55, n. 1, p. 25, doi. 10.4068/cmj.2019.55.1.25
- By:
- Publication type:
- Article
High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis.
- Published in:
- Acta Haematologica, 2020, v. 143, n. 4, p. 381, doi. 10.1159/000506498
- By:
- Publication type:
- Article
A fludarabine and melphalan reduced-intensity conditioning regimen for HSCT in fifteen chronic granulomatous disease patients and a literature review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 89, doi. 10.1007/s00277-013-1910-2
- By:
- Publication type:
- Article
Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6239, doi. 10.3390/jcm12196239
- By:
- Publication type:
- Article
Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies—Current Research and Clinical Approaches.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 1841, doi. 10.3390/jcm10091841
- By:
- Publication type:
- Article
Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2023, v. 261, n. 4, p. 1167, doi. 10.1007/s00417-022-05903-3
- By:
- Publication type:
- Article
Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2016, v. 254, n. 2, p. 391, doi. 10.1007/s00417-015-3202-0
- By:
- Publication type:
- Article
Investigating short-term toxicity of melphalan in a model of an isolated and superfused bovine retina.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2016, v. 254, n. 1, p. 91, doi. 10.1007/s00417-015-3149-1
- By:
- Publication type:
- Article
Differential binding of plasma proteins by liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the bilayer.
- Published in:
- Biochemistry (00062979), 2014, v. 79, n. 8, p. 797, doi. 10.1134/S0006297914080070
- By:
- Publication type:
- Article
Olanzapine versus Fosaprepitant for Chemotherapy-Induced Nausea and Vomiting Prophylaxis in Patients Receiving Single-Day High-Dose Melphalan.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 1, p. 37
- By:
- Publication type:
- Article
Impact of Weight-Based Melphalan Dosing Strategies in Autologous Hematopoietic Stem-Cell Transplant for Multiple Myeloma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 3, p. 135
- By:
- Publication type:
- Article
Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ERG and OCT abnormalities in retinoblastoma after melphalan intravitreous injection.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan-induced oral mucositis during hematological stem-cell transplantation: a prospective clinical study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Inhibition of HSP90 overcomes melphalan resistance through downregulation of Src in multiple myeloma cells.
- Published in:
- Clinical & Experimental Medicine, 2020, v. 20, n. 1, p. 63, doi. 10.1007/s10238-019-00587-2
- By:
- Publication type:
- Article
Paperspray Ionization Mass Spectrometry as a Tool for Predicting Real-Time Optimized Dosing of the Chemotherapeutic Drug Melphalan.
- Published in:
- Journal of Applied Laboratory Medicine, 2021, v. 6, n. 3, p. 625, doi. 10.1093/jalm/jfaa237
- Publication type:
- Article
Clinical and pathomorphological changes in the rabbit retina after an injection of various doses of the cytostatic melphalan.
- Published in:
- Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2023, n. 5, p. 41, doi. 10.31288/oftalmolzh202354145
- By:
- Publication type:
- Article
Ultrastructural changes in the rabbit retina after various one-time doses of intravitreal melphalan.
- Published in:
- Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2020, n. 4, p. 50, doi. 10.31288/oftalmolzh202045055
- By:
- Publication type:
- Article
Targeting liposomes loaded with melphalan prodrug to tumour vasculature via the Sialyl Lewis X selectin ligand.
- Published in:
- Journal of Drug Targeting, 2014, v. 22, n. 3, p. 242, doi. 10.3109/1061186X.2013.862805
- By:
- Publication type:
- Article
Impact of melphalan day -1 vs day -2 on outcomes after autologous stem cell transplant for multiple myeloma.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1310752
- By:
- Publication type:
- Article
A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide.
- Published in:
- 2010
- By:
- Publication type:
- journal article
DFT study of therapeutic potential of graphitic carbon nitride as a carrier for controlled release of melphalan: an anticancer drug.
- Published in:
- Journal of Molecular Modeling, 2022, v. 28, n. 11, p. 1, doi. 10.1007/s00894-022-05337-y
- By:
- Publication type:
- Article
Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Bortezomib With High-dose Melphalan Conditioning Regimen in Newly Diagnosed Multiple Myeloma Patients: Long-term Follow-up.
- Published in:
- In Vivo, 2025, v. 39, n. 1, p. 340, doi. 10.21873/invivo.13833
- By:
- Publication type:
- Article
Development and Validation of an HPLC- UV Method for the Determination of Melphalan from Lyophilized Nanosuspension.
- Published in:
- Indian Journal of Pharmaceutical Education & Research, 2019, v. 53, n. 2, p. 316, doi. 10.5530/ijper.53.2.40
- By:
- Publication type:
- Article
Anesthetic management of super‑selective intra‑arterial Melphalan injection in an infant with retinoblastoma.
- Published in:
- Saudi Journal of Anaesthesia, 2023, v. 17, n. 3, p. 434, doi. 10.4103/sja.sja_236_23
- By:
- Publication type:
- Article
A case of melphalan sustained accumulation in an 80-year old patient.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Development and Optimization of Lipid-polymer Hybrid Nanoparticles Containing Melphalan Using Central Composite Design and Its Effect on Ovarian Cancer Cell Lines.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2021, v. 20, n. 4, p. 213, doi. 10.22037/ijpr.2021.114575.14923
- By:
- Publication type:
- Article
Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75‐year‐olds newly diagnosed with multiple myeloma.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 6, p. 532, doi. 10.1111/ejh.13760
- By:
- Publication type:
- Article
Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 529, doi. 10.1111/ejh.13690
- By:
- Publication type:
- Article
Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 2, p. 275, doi. 10.1111/ejh.13650
- By:
- Publication type:
- Article
Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 6, p. 487, doi. 10.1111/ejh.12386
- By:
- Publication type:
- Article
Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma - a retrospective population based study of 1162 patients.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 1, p. 19, doi. 10.1111/ejh.12213
- By:
- Publication type:
- Article
The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15671, doi. 10.3390/ijms232415671
- By:
- Publication type:
- Article
Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14258, doi. 10.3390/ijms232214258
- By:
- Publication type:
- Article